Quantitative Systematic Strategies’s Iovance Biotherapeutics IOVA Stock Holding History

Quantitative Systematic Strategies’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,157	Closed	-$116K	–	517
2019 Q1	$116K	Sell	12,157 -918	-7%	-$8.92K	0.03%	349
2018 Q4	$116K	Buy	+13,075	New	+$126K	0.03%	596
2016 Q3	–	Sell	-22,452	Closed	-$178K	–	419
2016 Q2	$178K	Buy	+22,452	New	+$141K	0.08%	302
2015 Q2	–	Sell	-34,423	Closed	-$416K	–	558
2015 Q1	$416K	Buy	+34,423	New	+$388K	0.11%	246

Other funds holding IOVA

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return